血管内ステントグラフトの世界市場レポート 2025年

血管内ステントグラフトの市場規模は、今後数年で飛躍的な成長が見込まれます。2029年にはCAGR37.6％で51億9,000万米ドルに成長すると予測されます。予測期間の成長は、低侵襲手技への継続的なシフト、アテローム性動脈硬化症や肺塞栓症などの血管疾患の増加、有利な償還政策、病院数の増加、若い世代における糖尿病の増加に起因しています。予測期間における主な動向には、人工知能の統合、高度画像技術の革新、患者固有またはカスタマイズ可能なステントグラフトの開発、次世代組織工学人工血管の開発、技術の進歩などがあります。

心血管疾患の有病率の上昇は、血管内ステントグラフト市場の成長を将来的に押し上げると予想されています。心血管疾患（CVD）には、心臓や血管に影響を及ぼすさまざまな疾患が含まれます。これらの疾患の罹患率の増加は、ライフスタイルの選択、病状、遺伝的素因、環境の影響などさまざまな要因に起因しています。血管内ステントグラフトは、侵襲を最小限に抑え、患者の予後を向上させることに重点を置くことで、心血管疾患に対する効果的な治療選択肢を提供します。これらのステントグラフトは弱くなった血管壁を補強し、破裂を防ぎ、生命を脅かす合併症のリスクを低下させます。例えば、2023年12月、オーストラリアの政府機関であるオーストラリア保健福祉研究所のデータによると、冠動脈性心疾患（CHD）による医師認定の死亡者数は、2021年の1万4,100人から2022年には1万4,900人に増加したことが明らかになりました。その結果、心血管疾患の有病率の増加が血管内ステントグラフト市場の成長を促進しています。

血管内ステントグラフト市場の主要企業は、胸部大動脈瘤や解離の治療の精度と効果を向上させるため、胸部大動脈ステントグラフトなどの革新的製品の開発に注力しています。これらの進歩は、高度な技術と設計の改良を通じて、患者の転帰を向上させ、複雑な解剖学的課題に対処することを目的としています。胸部大動脈ステントグラフトは、胸部大動脈（胸部に位置する大動脈の一部）の疾患を管理するための血管内手術で使用される特殊な器具です。胸部大動脈疾患の治療において、安全性、有効性、利便性を兼ね備えています。例えば、2024年2月、中国の医療機器会社であるEndovastecは、Multi-Branch Thoracic Aortic Stent-Graft System (Hector)を発売し、スイスで最初の臨床応用を行いました。Hectorシステムは血管内ステントグラフト技術を大きく前進させるもので、重要な臓器に栄養を供給する重要な大動脈枝を温存し、適応させることにより、複雑な胸部大動脈疾患の治療を可能にします。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の血管内ステントグラフト市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の血管内ステントグラフト市場：成長率分析
• 世界の血管内ステントグラフト市場の実績：規模と成長、2019～2024年
• 世界の血管内ステントグラフト市場の予測：規模と成長、2024～2029年、2034年
• 世界の血管内ステントグラフト総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の血管内ステントグラフト市場：製品別、実績と予測、2019～2024年、2024～2029年、2034年
• 血液透析アクセスグラフト
• 血管内ステントグラフト
• 冠動脈バイパスグラフト
• 大動脈疾患用血管グラフト
• 末梢血管グラフト
• 世界の血管内ステントグラフト市場：原材料別、実績と予測、2019～2024年、2024～2029年、2034年
• 合成血管グラフト
• 生体血管グラフト
• ハイブリッド血管グラフト
• 世界の血管内ステントグラフト市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 心臓動脈瘤
• 腎不全
• 血管閉塞
• 冠動脈疾患
• 世界の血管内ステントグラフト市場：血液透析アクセスグラフトのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 動静脈瘻（AV）グラフト
• 合成血液透析アクセスグラフト
• バイオエンジニアリングによる血液透析アクセスグラフト
• コーティング血液透析グラフト
• 血管内血液透析グラフト
• 世界の血管内ステントグラフト市場：血管内ステントグラフトのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 動脈瘤ステントグラフト
• 大動脈解離用ステントグラフト
• 胸部血管内ステントグラフト
• 腹部血管内ステントグラフト
• 胆道血管内ステントグラフト
• 世界の血管内ステントグラフト市場：冠動脈バイパスグラフトのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 伏在静脈グラフト（SVG）
• 動脈冠動脈バイパスグラフト
• 血管内冠動脈バイパスグラフト（CABG）
• 合成冠動脈バイパスグラフト
• 世界の血管内ステントグラフト市場：大動脈疾患用血管グラフトのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 血管内大動脈ステントグラフト
• 大動脈瘤グラフト
• 大動脈バイパスグラフト
• 胸腹部大動脈ステントグラフト
• 大動脈解離ステントグラフト
• 世界の血管内ステントグラフト市場：末梢血管グラフトのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 頸動脈ステントグラフト
• 大腿動脈ステントグラフト
• 膝窩動脈ステントグラフト
• 腸骨動脈ステントグラフト
• 末梢血管内ステントグラフト

第7章 地域別・国別分析

• 世界の血管内ステントグラフト市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の血管内ステントグラフト市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 血管内ステントグラフト市場：競合情勢
• 血管内ステントグラフト市場：企業プロファイル
  • Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
  • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Becton, Dickinson and Company（BD）Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Boston Scientific Corporation
• Terumo Corporation
• Getinge AB
• Cook Group Incorporated
• Merit Medical Systems Inc.
• Biotronik SE & Co KG
• MicroPort Scientific Corporation
• Endologix LLC
• LeMaitre Vascular Inc.
• Lifetech Scientific Corporation
• W. L. Gore & Associates inc.
• Braile Biomedica
• BrosMed Medical BV
• Micro Interventional Devices Inc.（MID）
• Lombard Medical Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 血管内ステントグラフト市場2029：新たな機会を提供する国
• 血管内ステントグラフト市場2029：新たな機会を提供するセグメント
• 血管内ステントグラフト市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Endovascular stent grafts are medical devices used to address conditions affecting blood vessels, such as aneurysms or stenosis. They comprise a metal stent a small mesh tube covered with a fabric graft. The stent graft is introduced into the affected blood vessel via a catheter, usually inserted into a large artery in the groin or arm. These devices frequently repair aneurysms (enlarged sections of blood vessels) or other vessel damage, providing a less invasive alternative to traditional surgery.

The primary types of endovascular stent grafts include hemodialysis access grafts, endovascular stent grafts, coronary artery bypass grafts, vascular grafts for aorta diseases, and peripheral vascular grafts. Hemodialysis access grafts are specifically designed to provide an access point for hemodialysis in patients with kidney failure. Various materials, including synthetic, biological, and hybrid vascular grafts, are utilized in different applications such as cardiac aneurysms, kidney failure, vascular occlusion, and coronary artery diseases.

The endovascular stent grafts market research report is one of a series of new reports from The Business Research Company that provides endovascular stent grafts market statistics, including endovascular stent grafts industry global market size, regional shares, competitors with an endovascular stent grafts market share, detailed endovascular stent grafts market segments, market trends, and opportunities, and any further data you may need to thrive in the endovascular stent grafts industry. This endovascular stent market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The endovascular stent grafts market size has grown exponentially in recent years. It will grow from $1.05 billion in 2024 to $1.45 billion in 2025 at a compound annual growth rate (CAGR) of 37.8%. The growth in the historic period can be attributed to rise in the incidence of aortic aneurysms, rising aging population, increasing healthcare spending in developed regions, rise in number of ambulatory surgical centers, and rising incidence of chronic disease.

The endovascular stent grafts market size is expected to see exponential growth in the next few years. It will grow to $5.19 billion in 2029 at a compound annual growth rate (CAGR) of 37.6%. The growth in the forecast period can be attributed to ongoing shift towards minimally invasive procedures, increase in vascular diseases such as atherosclerosis, and pulmonary embolism, favorable reimbursement policies, increase in number of hospitals, and increasing diabetes even in the young generation. Major trends in the forecast period include integrating artificial intelligence, innovating advanced imaging technologies, developing of patient-specific or customizable stent grafts, developing of next-generation tissue-engineered vascular grafts, and technology advancements.

The rising prevalence of cardiovascular diseases is expected to boost the growth of the endovascular stent graft market in the future. Cardiovascular disease (CVD) encompasses a range of conditions affecting the heart and blood vessels. The increasing incidence of these diseases is attributed to various factors, including lifestyle choices, medical conditions, genetic predispositions, and environmental influences. Endovascular stent grafts provide an effective treatment option for cardiovascular diseases by focusing on minimizing invasiveness and enhancing patient outcomes. These stent grafts reinforce weakened vessel walls, preventing ruptures and lowering the risk of life-threatening complications. For example, in December 2023, data from the Australian Institute of Health and Welfare, an Australian government agency, revealed that the number of doctor-certified deaths due to coronary heart disease (CHD) rose from 14,100 in 2021 to 14,900 in 2022. Consequently, the increasing prevalence of cardiovascular diseases is driving the growth of the endovascular stent graft market.

Major companies in the endovascular stent graft market are concentrating on developing innovative products, such as thoracic aortic stent-grafts, to improve the precision and effectiveness of treating thoracic aortic aneurysms and dissections. These advancements aim to enhance patient outcomes and address complex anatomical challenges through advanced technology and design enhancements. A thoracic aortic stent graft is a specialized device used in endovascular surgery to manage diseases of the thoracic aorta, which is the section of the aorta located in the chest. It provides a combination of safety, efficacy, and convenience for treating thoracic aortic conditions. For example, in February 2024, Endovastec, a China-based medical device company, launched the Multi-Branch Thoracic Aortic Stent-Graft System (Hector) and carried out its first clinical application in Switzerland. The Hector system marks a significant step forward in endovascular stent graft technology, featuring a multi-branch design that allows for the treatment of complex thoracic aortic conditions by preserving and accommodating essential aortic branches, including those supplying vital organs.

In August 2022, W. L. Gore & Associates Inc. (Gore), a US-based company specializing in a variety of medical devices, acquired InnAVasc Medical Inc. for an undisclosed sum. This acquisition was strategically intended to strengthen Gore's position in the vascular sector by incorporating InnAVasc's advanced endovascular technologies. InnAVasc Medical Inc., also a US-based firm, is known for its production of endovascular stent grafts.

Major companies operating in the endovascular stent grafts market are Cardinal Health Inc., Abbott Laboratories, Medtronic PLC, Stryker Corporation, Becton, Dickinson and Company (BD), Boston Scientific Corporation, Terumo Corporation, Getinge AB, Cook Group Incorporated, Merit Medical Systems Inc., Biotronik SE & Co KG, MicroPort Scientific Corporation, Endologix LLC, LeMaitre Vascular Inc., Lifetech Scientific Corporation, W. L. Gore & Associates inc., Braile Biomedica, BrosMed Medical BV, Micro Interventional Devices Inc. (MID), Lombard Medical Inc.

North America was the largest region in the endovascular stent grafts market in 2024. The regions covered in the endovascular stent grafts market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the endovascular stent grafts market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The endovascular stent grafts market consists of sales of aortoiliac stent grafts, thoracic endograft, and abdominal endografts. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Endovascular Stent Grafts Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on endovascular stent grafts market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for endovascular stent grafts ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The endovascular stent grafts market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Hemodialysis Access Grafts; Endovascular Stent Grafts; Coronary Artery By-Pass Grafts; Vascular Grafts for Aorta Disease; Peripheral Vascular Grafts
• 2) By Raw Material: Synthetic Vascular Grafts; Biological Vascular Grafts; Hybrid Vascular Grafts
• 3) By Application: Cardiac Aneurysm; Kidney Failure; Vascular Occlusion; Coronary Artery Disease
• Subsegments:
• 1) By Hemodialysis Access Grafts: Arteriovenous (AV) Fistula Grafts; Synthetic Hemodialysis Access Grafts; Bioengineered Hemodialysis Access Grafts; Coated Hemodialysis Grafts; Endovascular Hemodialysis Grafts
• 2) By Endovascular Stent Grafts: Aneurysm Stent Grafts; Stent Grafts For Aortic Dissection; Thoracic Endovascular Stent Grafts; Abdominal Endovascular Stent Grafts; Biliary Endovascular Stent Grafts
• 3) By Coronary Artery By-Pass Grafts: Saphenous Vein Grafts (SVG); Arterial Coronary Bypass Grafts; Endovascular Coronary Artery Bypass Grafts (CABG); Synthetic Coronary Bypass Grafts
• 4) By Vascular Grafts For Aorta Disease: Endovascular Aortic Stent Grafts; Aortic Aneurysm Grafts; Aortic Bypass Grafts; Thoracoabdominal Aortic Stent Grafts; Aortic Dissection Stent Grafts
• 5) By Peripheral Vascular Grafts: Carotid Artery Stent Grafts; Femoral Artery Stent Grafts; Popliteal Artery Stent Grafts; Iliac Artery Stent Grafts; Peripheral Endovascular Stent Grafts
• Companies Mentioned: Cardinal Health Inc.; Abbott Laboratories; Medtronic PLC; Stryker Corporation; Becton, Dickinson and Company (BD)
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Endovascular Stent Grafts Market Characteristics

3. Endovascular Stent Grafts Market Trends And Strategies

4. Endovascular Stent Grafts Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Endovascular Stent Grafts Growth Analysis And Strategic Analysis Framework

• 5.1. Global Endovascular Stent Grafts PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Endovascular Stent Grafts Market Growth Rate Analysis
• 5.4. Global Endovascular Stent Grafts Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Endovascular Stent Grafts Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Endovascular Stent Grafts Total Addressable Market (TAM)

6. Endovascular Stent Grafts Market Segmentation

• 6.1. Global Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hemodialysis Access Grafts
• Endovascular Stent Grafts
• Coronary Artery By-Pass Grafts
• Vascular Grafts For Aorta Disease
• Peripheral Vascular Grafts
• 6.2. Global Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Synthetic Vascular Grafts
• Biological Vascular Grafts
• Hybrid Vascular Grafts
• 6.3. Global Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiac Aneurysm
• Kidney Failure
• Vascular Occlusion
• Coronary Artery Disease
• 6.4. Global Endovascular Stent Grafts Market, Sub-Segmentation Of Hemodialysis Access Grafts, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Arteriovenous (AV) Fistula Grafts
• Synthetic Hemodialysis Access Grafts
• Bioengineered Hemodialysis Access Grafts
• Coated Hemodialysis Grafts
• Endovascular Hemodialysis Grafts
• 6.5. Global Endovascular Stent Grafts Market, Sub-Segmentation Of Endovascular Stent Grafts, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Aneurysm Stent Grafts
• Stent Grafts For Aortic Dissection
• Thoracic Endovascular Stent Grafts
• Abdominal Endovascular Stent Grafts
• Biliary Endovascular Stent Grafts
• 6.6. Global Endovascular Stent Grafts Market, Sub-Segmentation Of Coronary Artery By-Pass Grafts, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Saphenous Vein Grafts (SVG)
• Arterial Coronary Bypass Grafts
• Endovascular Coronary Artery Bypass Grafts (CABG)
• Synthetic Coronary Bypass Grafts
• 6.7. Global Endovascular Stent Grafts Market, Sub-Segmentation Of Vascular Grafts For Aorta Disease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Endovascular Aortic Stent Grafts
• Aortic Aneurysm Grafts
• Aortic Bypass Grafts
• Thoracoabdominal Aortic Stent Grafts
• Aortic Dissection Stent Grafts
• 6.8. Global Endovascular Stent Grafts Market, Sub-Segmentation Of Peripheral Vascular Grafts, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Carotid Artery Stent Grafts
• Femoral Artery Stent Grafts
• Popliteal Artery Stent Grafts
• Iliac Artery Stent Grafts
• Peripheral Endovascular Stent Grafts

7. Endovascular Stent Grafts Market Regional And Country Analysis

• 7.1. Global Endovascular Stent Grafts Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Endovascular Stent Grafts Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Endovascular Stent Grafts Market

• 8.1. Asia-Pacific Endovascular Stent Grafts Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Endovascular Stent Grafts Market

• 9.1. China Endovascular Stent Grafts Market Overview
• 9.2. China Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Endovascular Stent Grafts Market

• 10.1. India Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Endovascular Stent Grafts Market

• 11.1. Japan Endovascular Stent Grafts Market Overview
• 11.2. Japan Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Endovascular Stent Grafts Market

• 12.1. Australia Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Endovascular Stent Grafts Market

• 13.1. Indonesia Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Endovascular Stent Grafts Market

• 14.1. South Korea Endovascular Stent Grafts Market Overview
• 14.2. South Korea Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Endovascular Stent Grafts Market

• 15.1. Western Europe Endovascular Stent Grafts Market Overview
• 15.2. Western Europe Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Endovascular Stent Grafts Market

• 16.1. UK Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Endovascular Stent Grafts Market

• 17.1. Germany Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Endovascular Stent Grafts Market

• 18.1. France Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Endovascular Stent Grafts Market

• 19.1. Italy Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Endovascular Stent Grafts Market

• 20.1. Spain Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Endovascular Stent Grafts Market

• 21.1. Eastern Europe Endovascular Stent Grafts Market Overview
• 21.2. Eastern Europe Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Endovascular Stent Grafts Market

• 22.1. Russia Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Endovascular Stent Grafts Market

• 23.1. North America Endovascular Stent Grafts Market Overview
• 23.2. North America Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Endovascular Stent Grafts Market

• 24.1. USA Endovascular Stent Grafts Market Overview
• 24.2. USA Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Endovascular Stent Grafts Market

• 25.1. Canada Endovascular Stent Grafts Market Overview
• 25.2. Canada Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Endovascular Stent Grafts Market

• 26.1. South America Endovascular Stent Grafts Market Overview
• 26.2. South America Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Endovascular Stent Grafts Market

• 27.1. Brazil Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Endovascular Stent Grafts Market

• 28.1. Middle East Endovascular Stent Grafts Market Overview
• 28.2. Middle East Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Endovascular Stent Grafts Market

• 29.1. Africa Endovascular Stent Grafts Market Overview
• 29.2. Africa Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Endovascular Stent Grafts Market Competitive Landscape And Company Profiles

• 30.1. Endovascular Stent Grafts Market Competitive Landscape
• 30.2. Endovascular Stent Grafts Market Company Profiles
  • 30.2.1. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Becton, Dickinson and Company (BD) Overview, Products and Services, Strategy and Financial Analysis

31. Endovascular Stent Grafts Market Other Major And Innovative Companies

• 31.1. Boston Scientific Corporation
• 31.2. Terumo Corporation
• 31.3. Getinge AB
• 31.4. Cook Group Incorporated
• 31.5. Merit Medical Systems Inc.
• 31.6. Biotronik SE & Co KG
• 31.7. MicroPort Scientific Corporation
• 31.8. Endologix LLC
• 31.9. LeMaitre Vascular Inc.
• 31.10. Lifetech Scientific Corporation
• 31.11. W. L. Gore & Associates inc.
• 31.12. Braile Biomedica
• 31.13. BrosMed Medical BV
• 31.14. Micro Interventional Devices Inc. (MID)
• 31.15. Lombard Medical Inc.

32. Global Endovascular Stent Grafts Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Endovascular Stent Grafts Market

34. Recent Developments In The Endovascular Stent Grafts Market

35. Endovascular Stent Grafts Market High Potential Countries, Segments and Strategies

• 35.1 Endovascular Stent Grafts Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Endovascular Stent Grafts Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Endovascular Stent Grafts Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250423_r33479_Endovascular_Stent_Grafts_GMR_2025